Predicting survival after veno-arterial extra corporeal membrane oxygenation (VA-ECMO) in the context of cardiac surgery.
Not Applicable
- Conditions
- ShockExtra corporeal membrane oxygenationSurvivalCardiac surgeryCardiovascular - Other cardiovascular diseasesAnaesthesiology - Other anaesthesiology
- Registration Number
- ACTRN12619001160123
- Lead Sponsor
- Dr Raymond Hu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Requiring veno-arterial extra-corporeal membrane oxygenation (VA-ECMO)
Post cardiotomy initiation of VA-ECMO
Adults (>18 years old)
Exclusion Criteria
Transfer to another facility whilst on VA-ECMO
Institution of VA-ECMO prior to cardiopulmonary bypass
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival to hospital discharge or 30 days after VA-ECMO initiation. This will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation.];Proportion of patients with successful decannulation (i.e. the ability to remove ECMO cannulae at least once). This will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation.];Proportion of patients with pooled major complications within 30 days of ECMO initiation: cannulation site bleeding, limb ischaemia, retroperitoneal haematoma, inadequate oxygenation, transfusion of four or more red blood cells, return to theatre. These will be assessed using the medical records and from the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZCTS) database.[Discharge or 30 days after VA-ECMO initiation. ]
- Secondary Outcome Measures
Name Time Method